Felix Lourdes 4
4 · LIXTE BIOTECHNOLOGY HOLDINGS, INC. · Filed Jul 2, 2026
Research Summary
AI-generated summary of this filing
Lixte (LIXT) Director Felix Lourdes Receives 30,000 RSU Award
What Happened
Felix Lourdes, a director of Lixte Biotechnology Holdings, received a grant of 30,000 restricted share units (RSUs) reported on July 1, 2026. The RSUs were awarded at $0.00 (no cash paid) and vested upon satisfaction of the applicable performance conditions. Each RSU represents a contingent right to receive one share of common stock upon vesting.
Key Details
- Transaction date and type: 2026-07-01 — Grant/Award (Code A) of 30,000 RSUs at $0.00 per RSU.
- Ownership reporting: the filing notes the total reported includes the 30,000 newly awarded RSUs plus 25,000 RSUs (all of which have vested), i.e., 55,000 RSUs referenced in the report.
- Filing timeliness: Form 4 was filed 2026-07-02 for a 2026-07-01 transaction (timely under Form 4 rules).
- Footnotes: (F1) RSUs granted under the 2020 Stock Incentive Plan; vested upon satisfaction of performance conditions. (F2) Column 5 totals include both the new 30,000 RSUs and 25,000 RSUs previously awarded.
Context
RSUs are a form of equity compensation, not an open-market purchase or sale. They create a contingent right to receive shares (and may dilute current holders when settled) and are typically granted to align insider incentives with company performance. Receipt of RSUs is routine compensation-related activity and does not, by itself, indicate insider buying or selling sentiment.
Insider Transaction Report
- Award
Common Stock
[F1][F2]2026-07-01+30,000→ 55,000 total
Footnotes (2)
- [F1]The reported transaction involved the Reporting Person's receipt of 30,000 restricted share units ("RSUs"). The RSUs were granted pursuant to the applicable RSU agreement and the Lixte Biotechnology Holdings, Inc. 2020 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock upon vesting, subject to continued service. The 30,000 RSUs vested upon the achievement of the performance conditions set forth in the Reporting Person's RSU agreement, which have been satisfied.
- [F2]The total reported in Column 5 includes (i) the 30,000 newly awarded RSUs, and (ii) 25,000 RSUs, all of which have vested.